These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28800166)

  • 21. Nivolumab therapy before vemurafenib administration induces a severe skin rash.
    Imafuku K; Yoshino K; Ymaguchi K; Tsuboi S; Ohara K; Hata H
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):e169-e171. PubMed ID: 27546003
    [No Abstract]   [Full Text] [Related]  

  • 22. 79-year Old Man on Nivolumab with Itchy Erythematous Patches.
    Copur MS; Corey S
    Oncology (Williston Park); 2020 Feb; 34(2):53-54. PubMed ID: 32645195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nivolumab Clearance Is Stationary in Patients With Resected Melanoma on Adjuvant Therapy: Implications of Disease Status on Time-Varying Clearance.
    Hamuro L; Statkevich P; Bello A; Roy A; Bajaj G
    Clin Pharmacol Ther; 2019 Nov; 106(5):1018-1027. PubMed ID: 31090921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.
    Finkelmeier F; Czauderna C; Perkhofer L; Ettrich TJ; Trojan J; Weinmann A; Marquardt JU; Vermehren J; Waidmann O
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):253-259. PubMed ID: 30374657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.
    Vitale MG; Scagliarini S; Galli L; Pignata S; Lo Re G; Berruti A; Defferrari C; Spada M; Masini C; Santini D; Ciuffreda L; Ruggeri EM; Bengala C; Livi L; Fagnani D; Bonetti A; Giustini L; Hamzaj A; Procopio G; Caserta C; Sabbatini R
    PLoS One; 2018; 13(7):e0199642. PubMed ID: 29979712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of melanoma combination immunotherapy.
    Baker H
    Lancet Oncol; 2017 Oct; 18(10):e565. PubMed ID: 28870612
    [No Abstract]   [Full Text] [Related]  

  • 27. Real world treatment practice in patients with advanced melanoma in the nivolumab era: five novel Italian case reports and a literature review.
    Depenni R; De Rossi C; De Tursi M; Marconcini R; Troiani T
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2490-2501. PubMed ID: 29762855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma.
    Komatsu T; Konishi K; Aoshima M; Tokura Y; Nakamura K
    Jpn J Radiol; 2018 Dec; 36(12):712-718. PubMed ID: 30206802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment.
    Dehghani L; Mikail N; Kramkimel N; Soyer P; Lebtahi R; Mallone R; Larger E
    Eur J Cancer; 2018 Nov; 104():243-246. PubMed ID: 30454710
    [No Abstract]   [Full Text] [Related]  

  • 30. An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.
    Veronesi G; Scarfì F; Misciali C; Tartari F; Melotti B; Patrizi A; Dika E
    Anticancer Drugs; 2019 Oct; 30(9):969-972. PubMed ID: 31205068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.
    Thapa B; Khalid S; Vakili R; Ui J; Misbah S
    Am J Ther; 2018; 25(6):e761-e763. PubMed ID: 29889678
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel use of combination therapeutic plasma exchange and rituximab in the treatment of nivolumab-induced bullous pemphigoid.
    Ridpath AV; Rzepka PV; Shearer SM; Scrape SR; Olencki TE; Kaffenberger BH
    Int J Dermatol; 2018 Nov; 57(11):1372-1374. PubMed ID: 29624655
    [No Abstract]   [Full Text] [Related]  

  • 33. Nivolumab-induced acute demyelinating polyradiculoneuropathy mimicking Guillain-Barré syndrome.
    Nukui T; Nakayama Y; Yamamoto M; Taguchi Y; Dougu N; Konishi H; Hayashi T; Nakatsuji Y
    J Neurol Sci; 2018 Jul; 390():115-116. PubMed ID: 29801870
    [No Abstract]   [Full Text] [Related]  

  • 34. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.
    Wada N; Uchi H; Furue M
    J Dermatol; 2017 Aug; 44(8):e196-e197. PubMed ID: 28391613
    [No Abstract]   [Full Text] [Related]  

  • 35. [Predictors of Nivolumab-Induced Skin Reactions].
    Osawa T; Inoue S; Umeda M; Hasegawa T; Makino T; Hori A; Tanaka K; Yasuda M; Mizui T; Sawa T; Sugiyama Y; Goto C
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1533-1535. PubMed ID: 30382069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.
    Kitano S; Tatsuno K; Ishibe J; Shimauchi T; Fujiyama T; Ito T; Ogawa N; Tokura Y
    Acta Derm Venereol; 2018 Jul; 98(7):704-705. PubMed ID: 29405244
    [No Abstract]   [Full Text] [Related]  

  • 37. Nivolumab in squamous cell carcinoma of the head and neck.
    Specenier P
    Expert Rev Anticancer Ther; 2018 May; 18(5):409-420. PubMed ID: 29560755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient.
    Teramoto Y; Nakamura Y; Asami Y; Imamura T; Takahira S; Nemoto M; Sakai G; Shimada A; Noda M; Yamamoto A
    J Dermatol; 2017 May; 44(5):605-606. PubMed ID: 27334247
    [No Abstract]   [Full Text] [Related]  

  • 39. Two cases of dabrafenib and trametinib therapy-failed advanced melanoma successfully controlled by nivolumab monotherapy.
    Sato Y; Fujimura T; Kambayashi Y; Tanita K; Tono H; Hashimoto A; Aiba S
    J Dermatol; 2018 Sep; 45(9):1105-1108. PubMed ID: 29923635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.
    Korman AM; Tyler KH; Kaffenberger BH
    Int J Dermatol; 2017 Apr; 56(4):e75-e77. PubMed ID: 28102540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.